WO2009127830A1 - Compositions for the treatment of lice - Google Patents
Compositions for the treatment of lice Download PDFInfo
- Publication number
- WO2009127830A1 WO2009127830A1 PCT/GB2009/000982 GB2009000982W WO2009127830A1 WO 2009127830 A1 WO2009127830 A1 WO 2009127830A1 GB 2009000982 W GB2009000982 W GB 2009000982W WO 2009127830 A1 WO2009127830 A1 WO 2009127830A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- lice
- composition according
- ectoparasitosis
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Definitions
- the present invention relates to compositions for treating lice infestations.
- Background to the Invention Infestation of the human body by lice is a prevalent social and health problem in many countries. There are three anatomically distinct types of lice that infest humans, namely head lice, body lice and crab lice.
- Head lice are small hard-shelled obligate ectoparasites that spend their entire life on the human scalp and feed exclusively on human blood.
- a female louse has a life span of 4 weeks, during which time it lays 50-100 eggs. Eggs are attached firmly to the hair shaft using chitin secreted by the female. The eggs hatch after 6-9 days, and the nymph emerges leaving behind the nonviable shell or "nit". Following three cycles of moulting, the nymph develops into an adult louse capable of reproducing. Head lice infestations are most common in children aged 4-11 , and are more prevalent in females than in males. Lice are spread by direct contact with an infested person.
- head lice can be signalled by itching caused by an allergic reaction to louse saliva. There may also be visual evidence of the presence of lice, eggs or nits.
- the objective when treating head lice infestations must be to free the host of eggs, nymphs, lice and nits, for the continued presence of the latter can only serve to confuse later diagnosis. It is preferable that the treatment be easy to carry out, inexpensive, and associated with minimal side-effects.
- Conventional head lice management usually involves the use of neurotoxic insecticide lotions in combination with wet combing.
- Combing using a fine-toothed plastic comb for the detection and removal of adult lice and a metal comb for eggs and nits, is viewed as a safe method of elimination but is a laborious process and a heavy burden on parents.
- Commonly used insecticidal treatments, or pediculicides are generally pyrethroid-based (e.g. Full Marks®), malathion-based (e.g. Derbac-M®) or carbaryl-based (e.g. Carylderm®).
- Pyrethroids such as permethrin and phenothrin, are synthetic axionic poisons which cause nervous hyper-excitability leading to death.
- Malathion is an organophosphate parasympathomimetic which binds irreversibly to cholinesterase.
- Carbaryl (1-naphthyl methylcarbamate) is also a cholinesterase inhibitor.
- Dimeticone-based products kill lice by inhibiting their ability to excrete surplus water. They are not traditional insecticides and have a good safety profile and are therefore recommended for pregnant or breastfeeding women. However, dimeticone is not thought to be effective in removing eggs from the host.
- the present invention relates to compositions suitable for use in the treatment of lice infestations.
- the present invention is also directed to methods of administering a composition such that lice, eggs and nits are eradicated from the host.
- a composition comprises glycerine, petrolatum and VP-hexadecene copolymer.
- such a composition is used in therapy, particularly for the topical treatment of ectoparasitosis.
- a method of treating ectoparasitosis comprises contacting the infested area of the subject with the composition of the invention.
- the present invention provides a composition that is useful in the topical treatment of ectoparasitosis, and in particular the treatment of pediculosis.
- ectoparasite is defined herein as a parasite that lives on the external surface of a host.
- ectoparasitosis refers to an infestation of ectoparasites.
- pediculosis refers to a lice infestation.
- the three genera of lice which affect humans are Pediculosis humanus capitis (head lice), Pediculosis humanus corporis (body lice) and Pthirus pubis (crab lice).
- the composition of the present invention is intended for use in the treatment of mammalian ectoparasitosis.
- the ectoparasitosis to be treated by use of the composition is pediculosis. More preferably, the pediculosis is a human lice infestation, and most preferably a head lice infestation.
- pediculicide refers to a pharmaceutical composition for the treatment of pediculosis.
- the terms "subject” and “host” are used interchangeably and refer to a mammal including a non-primate (e.g. a cow, pig, horse, cat, dog, rat and mouse) and a primate (e.g. a monkey and a human), and preferably a human.
- a non-primate e.g. a cow, pig, horse, cat, dog, rat and mouse
- a primate e.g. a monkey and a human
- composition of the invention is a liquid formulation comprising glycerine, petrolatum and vinylpyrrolidine (VP)/hexadecene copolymer.
- glycol is intended to encompass all terms used to describe the compound propane-1 ,2,3-triol which has the chemical formula HOCH 2 CH(OH)CH 2 OH.
- Petrolatum refers to pharmaceutical-grade or cosmetic-grade petrolatum and includes all synonyms including petroleum jelly and paraffin jelly. Petrolatum is a colourless to yellowish-white non-polar hydrocarbon mixture obtained by fractional distillation of petroleum and is commercially available under the brand name Vaseline®.
- VP/hexadecene copolymer refers to the coplymer of vinylpyrrolidine and long chain ⁇ -olefins. VP/hexadecene copolymer is a pale yellow viscous liquid commonly added to cosmetic products for its wear-resistance and moisture barrier-forming properties and is available commercially as Antaron®V-216 or Ganex®V-216.
- composition of the invention also comprises either, or both, pectin and xanthan gum.
- pectin' refers to a heteropolysaccharide derived from the cell wall of higher terrestrial plants that is commonly used as a gelling agent, a thickening agent and a stabilizer in food.
- the characteristic structure is a linear homogalacturonan with substituted regions of (1-2)-linked L-rhamnose.
- Isolated pectin is a white to light-brown powder and has a molecular weight of typically 60-130 000 g/mol, varying with origin and extraction conditions.
- 'xanthan gum' refers to a polysaccharide produced during the fermentation of glucose or sucrose by the Xanthomonas campestris bacterium. Xanthan gum is useful industrially since a very small quantity of gum (in the order of 0.5-1%) is capable of producing a large increase in the viscosity of a liquid.
- the composition comprises 0.1-5% w/w glycerine, 0.1-5% w/w petrolatum, 0.1-5% w/w VP-hexadecene polymer, 0.05-2 % w/w pectin and 0.05- 2 % w/w xanthan gum.
- the composition also comprises a surfactant, preferably an anionic surfactant.
- Suitable cosmetic-grade surfactants are known in the art and include sodium dodecasulphate (SDS), ammonium lauryl sulphate, sodium laureth sulphate, soaps and fatty acid salts.
- the pediculicide of the invention is a liquid formulation, preferably an aqueous lotion.
- Ingredients of the formulation include, but are not limited to, water, cosmetic-grade emollients such as cetearyl alcohol, emulsifiers such as steareth-21 , anti-static agents such as behentrimonium chloride, humectants such as propylene glycol, sorbitol, and glyceryl stearate citrate , moisturisers such as propylene glycol, preservatives such as parabens and phenoxyethanol and fragrant esters.
- the pediculicide is applied to the dry hair of an infested subject in a quantity sufficient to cover the entire area. It is preferable for the hair to then be wrapped in a plastic wrap or 'cling film'.
- the composition adheres to the hair shaft, forming a continuous impermeable film which prevents the lice and eggs from obtaining oxygen, thereby causing suffocation and death.
- the composition is left on the hair for a length of time sufficient to kill the lice and eggs by suffocation action.
- the composition is left on the hair for between 40 to 80 minutes, more preferably for 60 minutes, and then removed by rinsing with water.
- the presence of an anionic surfactant facilitates removal of the solution.
- Dead lice and eggs can be removed by wet combing the hair using a fine-toothed comb (teeth 0.2 to 0.3mm apart).
- subjects should preferably be treated twice a day for up to three days.
- the treatment is repeated after fifteen days to ensure eradication of any lice or eggs that may have persisted following the first treatment. Since the pediculicide of the invention employs a physical rather than biochemical mode of action, lice populations are not able to develop resistance and therefore the efficacy of the treatment will not decline over time.
- Example 1 The following efficacy study was performed on 13 subjects suffering from pediculosis. 11 of the subjects were female and 2 were male, and all were between the ages of 8 and 40 years old. In all subjects lice were found close to the scalp and itching was reported.
- Two versions of the pediculicide composition of the invention were prepared, one having a creamy consistency and one having a fluid consistency.
- the creamy version of the pediculicide was tested on 5 subjects and the fluid version was tested on 8 subjects.
- the components of the composition is as set out in Table 1.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2009237483A AU2009237483B2 (en) | 2008-04-16 | 2009-04-16 | Compositions for the treatment of lice |
CN2009801133578A CN102006858A (en) | 2008-04-16 | 2009-04-16 | Compositions for the treatment of lice |
CA2721649A CA2721649A1 (en) | 2008-04-16 | 2009-04-16 | Compositions for the treatment of lice |
EP09731992A EP2296623A1 (en) | 2008-04-16 | 2009-04-16 | Compositions for the treatment of lice |
IL208624A IL208624A0 (en) | 2008-04-16 | 2010-10-11 | Compositions for the treatment of lice |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0806948.6A GB0806948D0 (en) | 2008-04-16 | 2008-04-16 | Composition |
GB0806948.6 | 2008-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009127830A1 true WO2009127830A1 (en) | 2009-10-22 |
Family
ID=39472220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2009/000982 WO2009127830A1 (en) | 2008-04-16 | 2009-04-16 | Compositions for the treatment of lice |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2296623A1 (en) |
KR (1) | KR20110015524A (en) |
CN (1) | CN102006858A (en) |
AU (1) | AU2009237483B2 (en) |
CA (1) | CA2721649A1 (en) |
GB (1) | GB0806948D0 (en) |
IL (1) | IL208624A0 (en) |
WO (1) | WO2009127830A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20090122A1 (en) * | 2009-03-23 | 2010-09-24 | Marco Nicoletti | COMPOSITION FOR COSMETIC BASIC CREAM AND ITS PREPARATION PROCEDURE |
LU92931B1 (en) * | 2015-12-24 | 2017-07-20 | Pihuit S A | COMPOSITION AND METHOD OF PEST CONTROL |
WO2017198241A1 (en) * | 2016-05-19 | 2017-11-23 | Vakos Xt A.S. | A lice killing agent |
CZ307442B6 (en) * | 2017-04-18 | 2018-08-22 | Vakos Xt A.S. | A composition for killing lice |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB564729A (en) * | 1940-06-26 | 1944-10-11 | Cooper Mcdougall & Robertson | Improved insecticide |
GB572310A (en) * | 1942-12-31 | 1945-10-02 | Mckesson & Robbins Inc | Parasiticides |
WO2000072814A1 (en) * | 1999-05-27 | 2000-12-07 | Eduardo Zancaner | Composition for cleaning and removing parasites from the hair |
WO2002053120A2 (en) * | 2001-01-08 | 2002-07-11 | Beiersdorf Ag | Cosmetic and dermatological light protection formulations containing benzotriazole derivatives and surfactant sucrose esters |
US20050106190A1 (en) * | 2001-12-18 | 2005-05-19 | Rolf Kawa | Cosmetic and/or pharmaceutical emulsions |
WO2007085899A2 (en) * | 2005-07-06 | 2007-08-02 | Foamix Ltd. | Foamable arthropocidal composition for tropical application |
-
2008
- 2008-04-16 GB GBGB0806948.6A patent/GB0806948D0/en not_active Ceased
-
2009
- 2009-04-16 AU AU2009237483A patent/AU2009237483B2/en not_active Expired - Fee Related
- 2009-04-16 KR KR1020107023989A patent/KR20110015524A/en not_active Application Discontinuation
- 2009-04-16 CN CN2009801133578A patent/CN102006858A/en active Pending
- 2009-04-16 CA CA2721649A patent/CA2721649A1/en not_active Abandoned
- 2009-04-16 EP EP09731992A patent/EP2296623A1/en not_active Withdrawn
- 2009-04-16 WO PCT/GB2009/000982 patent/WO2009127830A1/en active Application Filing
-
2010
- 2010-10-11 IL IL208624A patent/IL208624A0/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB564729A (en) * | 1940-06-26 | 1944-10-11 | Cooper Mcdougall & Robertson | Improved insecticide |
GB572310A (en) * | 1942-12-31 | 1945-10-02 | Mckesson & Robbins Inc | Parasiticides |
WO2000072814A1 (en) * | 1999-05-27 | 2000-12-07 | Eduardo Zancaner | Composition for cleaning and removing parasites from the hair |
WO2002053120A2 (en) * | 2001-01-08 | 2002-07-11 | Beiersdorf Ag | Cosmetic and dermatological light protection formulations containing benzotriazole derivatives and surfactant sucrose esters |
US20050106190A1 (en) * | 2001-12-18 | 2005-05-19 | Rolf Kawa | Cosmetic and/or pharmaceutical emulsions |
WO2007085899A2 (en) * | 2005-07-06 | 2007-08-02 | Foamix Ltd. | Foamable arthropocidal composition for tropical application |
Non-Patent Citations (1)
Title |
---|
FOWLER J F: "Allergic contact dermatitis to polyvinylpyrrolidone/hexadecene copolymer", AMERICAN JOURNAL OF CONTACT DERMATITIS, SAUNDERS, HARCOURT BRACE JOVANOVICH, PHILADELPHIA, PA, US, vol. 6, no. 4, 1 December 1995 (1995-12-01), pages 243 - 244, XP004528385, ISSN: 1046-199X * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20090122A1 (en) * | 2009-03-23 | 2010-09-24 | Marco Nicoletti | COMPOSITION FOR COSMETIC BASIC CREAM AND ITS PREPARATION PROCEDURE |
LU92931B1 (en) * | 2015-12-24 | 2017-07-20 | Pihuit S A | COMPOSITION AND METHOD OF PEST CONTROL |
WO2017198241A1 (en) * | 2016-05-19 | 2017-11-23 | Vakos Xt A.S. | A lice killing agent |
CZ307442B6 (en) * | 2017-04-18 | 2018-08-22 | Vakos Xt A.S. | A composition for killing lice |
Also Published As
Publication number | Publication date |
---|---|
AU2009237483A1 (en) | 2009-10-22 |
KR20110015524A (en) | 2011-02-16 |
EP2296623A1 (en) | 2011-03-23 |
AU2009237483B2 (en) | 2012-05-10 |
GB0806948D0 (en) | 2008-05-21 |
IL208624A0 (en) | 2010-12-30 |
CA2721649A1 (en) | 2009-10-22 |
CN102006858A (en) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6541455B2 (en) | Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents | |
DE60006556T2 (en) | METHOD AND COMPOSITION FOR COMBATING ARTHROPODES | |
US6607716B1 (en) | Pediculicidal compositions, a kit, and methods of use | |
US20060121073A1 (en) | Topical gel formulation comprising insecticide and its preparation thereof | |
US20080118585A1 (en) | Natural compositions for killing parasites on a companiion animal | |
EP2750680B1 (en) | Composition for treating lice infestation | |
US9955695B2 (en) | Pediculicide/ovicide composition | |
AU2009237483B2 (en) | Compositions for the treatment of lice | |
EP2081428B1 (en) | Antipediculosis composition having a lice-suffocating activity | |
EP3424321A1 (en) | Compounds for treating ectoparasite infestation | |
EP2470006B1 (en) | Use of a microemulsion for controlling lice | |
WO2024201283A1 (en) | Insecticidal and arachnidicidal compositions and uses thereof | |
US20060084632A1 (en) | Topical gel formulation comprising organophosphate insecticide and its preparation thereof | |
US20120172338A1 (en) | Topical gel formulation comprising organophosphate insecticide and its preparation thereof | |
RU2340181C1 (en) | Insectoacaricide agent insektal-plus | |
DE69709317T2 (en) | ANTISEPTIC COMPOSITIONS BASED ON CHLOROBUTANOL AND CHLORHEXIDINE | |
WO2024218775A1 (en) | Compositions for treating lice infestations | |
US20050165104A1 (en) | Biocidal agents and veterinary methods | |
FR3075040A1 (en) | PEST CONTROL COMPOSITION FOR EXTERNAL USE | |
Sakr et al. | Assessment of Essential Oils Treatment of Neem Extract Versus Ivermectin Against Sarcoptes scabiei In Rabbit Flocks | |
WO2001012173A1 (en) | Low concentration pest treatment composition and method | |
Patyk | Practical evaluation of insecticides and their application | |
WO2019115980A1 (en) | Antiparasitic composition for external use | |
FR3042119A1 (en) | VETERINARY COMPOSITIONS FOR CONTROLLING PHLEBOTOMAS | |
FR2691358A1 (en) | Undecylenic and undecanoic acid derivs. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980113357.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09731992 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12010502317 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 7251/DELNP/2010 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2721649 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009237483 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20107023989 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009731992 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2009237483 Country of ref document: AU Date of ref document: 20090416 Kind code of ref document: A |